OTC:ACUT | Free Cash Flow | Accustem Sciences Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$374,176.00
2025-12-31$22,357.00
2025-03-31-$290,182.00
2024-12-31$414.00
2024-03-31-$237,351.00
2023-12-31-$295,031.00
2023-03-31-$446,090.00
2022-12-31-$622,261.00$0.00-$622,261.00
2022-03-31$371,984.00$8,203.00$363,781.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$850,389.00
2024-12-31-$664,066.00
2023-12-31-$1.62M
2022-12-31-$1.81M$10,999.00-$1.82M